SANUWAVE Health, Inc. (SNWV)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$4.38-1.57%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · SNWV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 44.2 | 44.1 | 32.6 | 20.4 | 16.7 | 13.0 | 4.1 | 1.5 | 1.9 | 0.7 | 1.4 | 1.0 | 0.8 | 0.8 | 0.8 | 0.8 |
| Total Revenues | 44.2 | 44.1 | 32.6 | 20.4 | 16.7 | 13.0 | 4.1 | 1.5 | 1.9 | 0.7 | 1.4 | 1.0 | 0.8 | 0.8 | 0.8 | 0.8 |
| Cost of Revenues | 10.4 | 10.1 | 8.1 | 6.0 | 4.3 | 5.0 | 1.2 | 0.5 | 0.7 | 0.2 | 0.6 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 |
| Gross Profit | 33.8 | 34.0 | 24.6 | 14.4 | 12.4 | 8.0 | 2.9 | 0.5 | 1.2 | — | — | 0.7 | 0.6 | 0.6 | 0.5 | 0.5 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 2.2 | 1.4 | 0.7 | 0.6 | 0.6 | 1.1 | 1.2 | 1.2 | 1.0 | 1.3 | 1.1 | 2.2 | 3.0 | 2.3 | 1.8 | 2.7 |
| Operating Income | 2.1 | 4.9 | 5.4 | (0.5) | (9.0) | (14.1) | (25.2) | (8.8) | (7.2) | (3.8) | (3.3) | (4.4) | (6.0) | (6.0) | (6.1) | (8.8) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | 1.8 | 4.5 | 1.1 | 0.9 | 0.4 | 0.4 | 0.4 | 0.3 | 0.5 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | (1.6) | (4.5) | (1.7) | (3.1) | (0.4) | — | — | — | (1.4) |
| Asset Writedown | — | 0.2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | 11.9 | — | — | — | — | — | — | — | — | — | — | (6.0) | (12.0) | (6.4) | (10.2) |
| Income Tax Expense | — | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | 0.0 | 0.0 | 0.0 | (0.2) |
| Net Income | ||||||||||||||||
| Net Income | 15.9 | 11.8 | (31.4) | (25.8) | (10.3) | (27.3) | (30.9) | (10.4) | (11.6) | (5.5) | (6.4) | (4.8) | (6.0) | (11.3) | (6.4) | (10.2) |
| Per Share | ||||||||||||||||
| Basic EPS | 1.85 | 1.38 | (7.03) | (12.19) | (0.02) | (0.05) | (0.08) | — | — | — | — | — | — | — | (0.30) | (0.52) |
| Diluted EPS | 1.85 | 0.41 | (7.03) | (12.19) | (0.02) | (0.05) | (0.08) | — | — | — | — | — | — | — | (0.30) | (0.52) |
| Revenue per Share | 5.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.6 | 8.6 | 4.5 | 2.1 | 549.5 | 518.4 | 378.1 | — | — | — | — | — | — | — | 20.9 | 19.6 |
| Diluted Weighted Avg Shares | 8.6 | 9.1 | 4.5 | 2.1 | 549.5 | 518.4 | 378.1 | — | — | — | — | — | — | — | 20.9 | 19.6 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 5.8 | 6.2 | 0.2 | (8.2) | (13.4) | (24.4) | — | — | — | — | — | — | — | — | — |
| EBIT | 2.1 | 4.9 | 5.4 | (0.5) | (9.0) | (14.1) | (25.2) | (8.8) | (7.2) | (3.8) | (3.3) | (4.4) | (6.0) | (6.0) | (6.1) | (8.8) |
| Effective Tax Rate | — | — | — | — | — | — | — | — | — | — | — | — | 0.0% | 0.0% | 0.0% | 2.3% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.